Lu Liang, Lu Yan, Zhang Longyi
Department of Reproductive Center, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, People's Republic of China.
Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, People's Republic of China.
Int J Womens Health. 2024 May 31;16:1033-1040. doi: 10.2147/IJWH.S455733. eCollection 2024.
Female infertility is a global health concern. The aim of this study was to investigate the relationship between regulatory T (Treg) cells and helper T cells 17 (Th17) in peripheral blood and unexplained infertility (UI). In addition, we explored potential valuable diagnostic biomarkers for patients with UI and ascertained whether Treg and Th17 cells are associated with primary and secondary UI.
The patients underwent standard fertility evaluation test, including blood tests, ultrasound examination, fallopian tube tests, ovulation assessment, and male partner's semen analysis. According to the inclusion and exclusion criteria, this study enrolled 37 patients with UI (30 with primary UI and 7 with secondary UI) and 26 age-matched healthy volunteers as the control group. Flow cytometry was used to detect the frequency of Treg and Th17 cells. The area under the receiver operating characteristic curve (AUC) with a 95% confidence interval (CI) was used to assess the diagnostic performance. An AUC > 0.800 indicated good diagnostic performance.
The percentage of Treg decreased significantly, whereas the percentage and absolute count of Th17 cells increased. Moreover, the Th17/Treg ratio in patients with UI increased significantly. As a diagnostic biomarker for UI, the Th17/Treg ratio exhibited remarkable diagnostic performance (AUC: 0.813 (95% CI = 0.709-0.917)). However, the percentages and absolute counts of Treg and Th17 cells in the peripheral blood of women with primary and secondary UI, as well as their Th17/Treg ratios, did not differ significantly.
The distribution of Treg and Th17 cells is imbalanced in patients with UI. Therefore, the Th17/Treg ratio may be a promising indicator of UI. However, there were no significant differences in the distribution of Treg and Th17 cells between women with primary and secondary UI.
女性不孕症是一个全球性的健康问题。本研究旨在探讨外周血中调节性T(Treg)细胞和辅助性T细胞17(Th17)与不明原因不孕症(UI)之间的关系。此外,我们探索了对UI患者具有潜在价值的诊断生物标志物,并确定Treg和Th17细胞是否与原发性和继发性UI相关。
患者接受了标准的生育评估测试,包括血液检查、超声检查、输卵管检查、排卵评估以及男性伴侣的精液分析。根据纳入和排除标准,本研究招募了37例UI患者(30例原发性UI患者和7例继发性UI患者)以及26例年龄匹配的健康志愿者作为对照组。采用流式细胞术检测Treg和Th17细胞的频率。使用具有95%置信区间(CI)的受试者工作特征曲线(AUC)下面积来评估诊断性能。AUC>0.800表示诊断性能良好。
Treg细胞百分比显著降低,而Th17细胞的百分比和绝对计数增加。此外,UI患者的Th17/Treg比值显著升高。作为UI的诊断生物标志物,Th17/Treg比值表现出显著的诊断性能(AUC:0.813(95%CI = 0.709 - 0.917))。然而,原发性和继发性UI女性外周血中Treg和Th17细胞的百分比、绝对计数及其Th17/Treg比值并无显著差异。
UI患者中Treg和Th17细胞的分布失衡。因此,Th17/Treg比值可能是UI的一个有前景的指标。然而,原发性和继发性UI女性之间Treg和Th17细胞的分布没有显著差异。